A Lone Voice Raises Alarms on Lucrative Diabetes Drugs

Dr. Peter C. Butler initially declined a request by the drug maker Merck to test whether its new diabetes drug, Januvia, could help stave off the disease in rats.

“I said, I’m not interested in your money, go away,” Dr. Butler recalled.

Merck no doubt now wishes it had. When Dr. Butler finally agreed to do the study, he found worrisome changes in the pancreases of the rats that could lead to pancreatic cancer. Read more

AUTHOR

Sripathi R. Kethu, M.D. FACG.

Sripathi R. Kethu, M.D. FACG.

Dr Kethu is a practicing Gastroenterologist. He is a healthcare and real estate entrepreneur. He writes frequently on topics related to health care, healthy living, and physical fitness. He is the author of Amazon’s best-selling book, “The IBS Guide”. He is an avid marathon runner and is on track to finish his 100th marathon in 2024.

Leave a Comment